Stroke continues to be a major health problem for our society. Despite the
availability of tissue plasminogen activator (tPA), only a minority of pati
ents qualify for this type of therapy. Furthermore, for patients with occlu
sion of large cerebral arteries, tPA does not seem to be as effective. Cons
idering the benefits and risks for appropriate treatment of this population
, they are the best candidates for neuroendovascular rescue by means of: di
rect mechanical disruption, angioplasty, stenting, embolectomy, and pharmac
ologic intervention. The timing and choice of these procedures, and the car
e of the patient prior to, during, and after the intervention require a hig
hly focused and expert approach.